Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2420027 | 0.84 | — | — | |
| SCHEMBL341318 | 0.80 | SMN1; SMN2 (0.34) | SMN1; SMN2SIGMAR1KDM4EHSD17B10ALDH1A1 | |
| SCHEMBL12463624 | 0.80 | MEN1 (0.50) | SMN1; SMN2MEN1KMT2ASIGMAR1KDM4E | |
| SCHEMBL342302 | 0.78 | SMN1; SMN2 (0.38) | SMN1; SMN2GAASIGMAR1HSD17B10ALDH1A1 | |
| SCHEMBL15541721 | 0.78 | SMN1; SMN2 (0.38) | SMN1; SMN2GAASIGMAR1HSD17B10ALDH1A1 | |
| SCHEMBL9957046 | 0.77 | POLB (0.38) | SMN1; SMN2MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL9957528 | 0.77 | HTT (0.40) | SIGMAR1KDM4EALDH1A1RECQLALOX15 | |
| SCHEMBL17392772 | 0.76 | SMN1; SMN2 (0.43) | SMN1; SMN2MEN1KMT2AGAASIGMAR1 | |
| SCHEMBL19971101 | 0.75 | SIGMAR1 (0.39) | SMN1; SMN2MEN1KMT2ASIGMAR1ALDH1A1 | |
| SCHEMBL20531089 | 0.75 | GAA (0.35) | GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2651876-B1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECH AG (CH) | 2017-08-09 | — | — | EP | claimed |
| CN-102648230-B | The extremely low low viscosity epoxy resin compositions of blushing | SIKA技术股份公司 | 2017-03-01 | — | — | CN | claimed |
| CN-103313995-B | Secondary aminosilanes | SIKA技术股份公司 | 2016-08-10 | — | — | CN | claimed |
| CN-103261146-B | Polyamines having secondary aliphatic amino groups | SIKA TECHNOLOGY AG (CH) | 2016-01-27 | — | — | CN | claimed |
| US-8877955-B2 | Secondary aminosilanes | SIKA TECHNOLOGY AG (CH) | 2014-11-04 | — | — | US | claimed |
| US-8703844-B2 | Low-viscosity epoxy resin composition with low blushing | SIKA TECHNOLOGY AG (CH) | 2014-04-22 | — | — | US | claimed |
| US-20130281562-A1 | SECONDARY AMINOSILANES | SIKA TECHNOLOGY AG (CH) | 2013-10-24 | — | — | US | claimed |
| EP-2651876-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | Sika Technology AG (CH) | 2013-10-23 | — | — | EP | claimed |
| EP-2651956-A1 | SECONDARY AMINOSILANES | Sika Technology AG (CH) | 2013-10-23 | — | — | EP | claimed |
| US-20130261270-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2013-10-03 | — | — | US | claimed |
| CN-103261146-A | Polyamines having secondary aliphatic amino groups | SIKA TECHNOLOGY AG | 2013-08-21 | — | — | CN | claimed |
| US-20120270967-A1 | LOW-VISCOSITY EPOXY RESIN COMPOSITION WITH LOW BLUSHING | SIKA TECHNOLOGY AG (CH) | 2012-10-25 | — | — | US | claimed |
| CN-102648230-A | Low-viscosity epoxy resin composition with low blushing | SIKA TECHNOLOGY AG | 2012-08-22 | — | — | CN | claimed |
| EP-2336213-B1 | Low viscosity epoxide resin compound with low blushing | SIKA TECHNOLOGY AG (CH) | 2012-08-01 | — | — | EP | claimed |
| EP-2468759-A1 | Secondary Aminosilanes | Sika Technology AG (CH) | 2012-06-27 | — | — | EP | claimed |
| WO-2012080266-A1 | SECONDARY AMINOSILANES | SIKA TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | claimed |
| WO-2012080265-A1 | POLYAMINES HAVING SECONDARY ALIPHATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2012-06-21 | — | — | WO | claimed |
| EP-2465843-A1 | Polyamines with secondary aliphatic amines | Sika Technology AG (CH) | 2012-06-20 | — | — | EP | claimed |
| EP-2336213-A1 | Low viscosity epoxide resin compound with low blushing | Sika Technology AG (CH) | 2011-06-22 | — | — | EP | claimed |
| WO-2011069846-A1 | LOW-VISCOSITY EPOXY RESIN COMPOSITION WITH LOW BLUSHING | SIKA TECHNOLOGY AG (CH) | 2011-06-16 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281562-A1 | SECONDARY AMINOSILANES | AS3MT, SRM, MSN | SMN1; SMN2 542/4885MEN1 2889/4885KMT2A 293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.